Home | EndoTODAY | EndoATLAS

Beginner | ESA | Schedule | OPD

Seminars | Atlas | Recent | Links

EndoTODAY ³»½Ã°æ ±³½Ç


[On-line seminars. ¿Â¶óÀÎ ¼¼¹Ì³ª] - Hands-on Schedule, ðû

2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | Quiz


[2025]

2025-31. ESD complications. ¿À¿µÀº/ÀÌÁØÇà

2025-4-30

2025-30. (1) MALToma ÀÇÁõ, (2) ³¯¹® À§¾Ï

2025-4-28

2025-29. GERD, Helicobacter

ÀÌÁØÇà, ±èż¼, À¯Çý¼ö. 2025-4-15

2025-28. Á¶Á÷°Ë»ç·Î ÀÎÇÑ ½Äµµ õ°ø µî

2025-4-22

2025-27. Á¶±âÀ§¾Ï ³»½Ã°æÄ¡·á, ¹ÌºÐÈ­Á¶Á÷Çü À§¾ÏÀÇ Ä¡·á¹ý ¼±ÅÃ, BGU ÅäÇ÷, ¾Æ¸Þ¹Ù Àå¿° µî

2025-4-15

2025-26. À§Ã༺ À§¿° ³»½Ã°æ ¼Ò°ß

2025-4-1

2025-25. Bowel preparation. ±è¹ÎÁö

2025-3-17

2025-24. Cardia EGC with SM invasion and gastritis cystica profunda (Cancer 724/ECR 035)

2025-3-7

2025-23. ÁøÇ༺ À§¾Ï Áõ·Ê ÅäÀÇ. ¸Å¿ì ¾Æ³ª·Î±×ÇÑ °á°úÁö

2025-3-5

2025-22. Sentinel polyp. º¸ÃÊ¿ëÁ¾ (EndoTODAY º¸ÃÊ ¿ëÁ¾)

2025-3-4

[2025-3-4. ÀÌÁØÇà Facebook °ø°³ Áú¹®] Sentinel polypÀ̶ó´Â ¿ëÁ¾ÀÌ Àִµ¥ ÀÌ Á¾·ù°¡ ¿Ö º¸ÃÊ ¿ëÁ¾À̶ó°í ºÒ¸®°Ô µÇ¾ú´ÂÁö Àú´Â ¾ËÁö ¸øÇÕ´Ï´Ù. ¾Ë°í °è½Å ºÐÀº Àú¿¡°Ô ¿¬¶ôÁֽñ⠹ٶø´Ï´Ù.

[2025-3-4. ±è¿ë¼º ¿øÀå´Ô ´äº¯] Reflux esophagitis¿Í ¿¬°üµÇ¾î fold thickening or polypÀ» ³»½Ã°æÀ¸·Î °üÂûÇÏ°í ¸í¸íÇß´Ù°í Çϴµ¥, ¿Ö ±×·¸°Ô ºÙ¿´´ÂÁö ã±â´Â ¾î·Æ³×¿ä. Esophagogram¿¡¼­ º¸ÀÌ´Â ¸ð¾çÀÌ º¸Ãʰ¡ ¼­ ÀÖ´Â °Í °°±âµµ Çϰí¿ä. (Abdom Radiol 2021)

ChatGPTÀÇ ¼³¸íÀÌ ´õ ±×·²µí ÇØº¸À̱⵵ ÇÕ´Ï´Ù.^^ "Sentinel polyp ¿ë¾îÀÇ ¿ª»çÀû À¯·¡: ÀÌ ¿ë¾î´Â ¿ø·¡ Ç×¹®(anal fissure)¿¡¼­ ¹ß°ßµÇ´Â sentinel tag(¶Ç´Â sentinel pile)¿¡¼­ À¯·¡Çß½À´Ï´Ù. Ç×¹® ÁÖº¯¿¡¼­´Â ¸¸¼ºÀûÀÎ ±Õ¿­(anal fissure)ÀÌ ÀÖÀ¸¸é Ç×¹® °¡ÀåÀÚ¸®¿¡ º¸È£ ¹ÝÀÀÀ¸·Î ¼¶À¯¼º Á¶Á÷(fibrous tissue)ÀÌ Áõ½ÄÇϸ鼭 ÀÛÀº °áÀý ÇüÅÂÀÇ º´º¯ÀÌ Çü¼ºµÇ´Âµ¥, À̸¦ **sentinel pile(polyp)**À̶ó°í ºÒ·¶½À´Ï´Ù. ÀÌ·¯ÇÑ °³³äÀÌ ½ÄµµÀÇ ¸¸¼º ¼Õ»ó¿¡¼­µµ ºñ½ÁÇÑ º´¸®ÇÐÀû ¾ç»óÀÌ ³ªÅ¸³­´Ù´Â Á¡¿¡¼­ ½Äµµ¿¡¼­µµ sentinel polypÀ̶ó´Â ¿ë¾î°¡ Àû¿ëµÈ °ÍÀ¸·Î º¸ÀÔ´Ï´Ù."

[2025-3-5. ÀÌÁØÇà ´äº¯] ±è¿ë¼º ¿øÀå´Ô. ÁÁÀº comment °¨»çÇÕ´Ï´Ù. ¾Æ, ±×·¸±¸³ª. AI¿¡ ¹°¾îºÁ¾ßÁö.... »ý°¢ÀÌ µé¾î¼­ Àúµµ Á¦¹Ì´Ï¿¡°Ô ¹°¾îº¸¾Ò½À´Ï´Ù. ÀÌ·± ´äº¯À» ¹Þ¾Ò½À´Ï´Ù. "¼¾Æ¼³Ú Æú¸³Àº ¸¸¼º Ä¡¿­À̳ª Ç×¹® ±Ë¾çÀÇ °á°ú·Î Ç×¹® ÁÖº¯¿¡ ³ªÅ¸³ª´Â ÀÛÀº ÇǺΠµ¹Ãâ¹°ÀÔ´Ï´Ù. SentinelÀ̶ó´Â À̸§Àº 'º¸Ãʺ´'À̶ó´Â ¶æÀ¸·Î, ÀÌ Æú¸³ÀÌ Ç×¹® ÁúȯÀÇ 'º¸Ãʺ´' ¿ªÇÒÀ» ÇÑ´Ù´Â Àǹ̿¡¼­ ºÙ¿©Á³½À´Ï´Ù." »ç½Ç Àú´Â ÄĸÍÀÔ´Ï´Ù. Àú¸¦ ÄÄÇ»ÅÍ ±Í½ÅÀ¸·Î ¾Æ´Â ºÐµµ °è½Ã´Âµ¥ ¿ÏÀüÈ÷ ÄĸÍÀÔ´Ï´Ù. ÄÄÇ»ÅÍ ºÐ¾ß¿¡¼­´Â µµ¹«Áö »õ·Î¿î °ÍÀ» ½ÃµµÇÏÁö ¾Ê°í ÀÖ½À´Ï´Ù. 1999³â ±ºÀǰü ½ÃÀý µ¿·á¿´´ø ÃÖÁøÈ£ ±ºÀǰü (Çö »ï¼º¼­¿ïº´¿ø ÀÀ±ÞÀÇÇаú ±³¼ö)·ÎºÎÅÍ ¹è¿î HTMLÀ» ¾ÆÁ÷µµ ¸Þ¸ðÀåÀ» ÀÌ¿ëÇÏ¿© ÀÛ¼ºÇϰí ÀÖÀ» »ÓÀÔ´Ï´Ù. ±×·±µ¥ ChatGPT¸¦ ÀÌ¿ëÇÑ ¼±»ý´ÔÀÇ ´äº¯°ú ¿À´Ã Á¦¹Ì´Ï¿¡°Ô ¹°¾îº» ÀúÀÇ °æÇèÀ¸·Î ÀÌÁ¦ Àúµµ AI ½Ã´ë¿¡ ¸Â°Ô º¯½ÅÇØ¾ß ÇÒ °Í °°´Ù´Â »ý°¢À» ÇÏ°Ô µË´Ï´Ù. ÀºÅðÁغñ¿¡ ¹Ù»Û ¿äÁîÀ½ (»ç½Ç 20¿©³â ÀüºÎÅÍ ÀºÅðÁغñ¸¦ Çϰí ÀÖ½À´Ï´Ù¸¸...) AI¶ó´Â »õ·Î¿î Èï¹Ì°Å¸®°¡ »ý°å½À´Ï´Ù.

[2025-3-5. ±è¿ë¼º ¿øÀå´Ô Ãß°¡ comment] À̹ø¿¡ ã¾Æº¸±â Àü¿¡ ¸·¿¬ÇÏ°Ô ¿°ÁõÀ» ½Ã»çÇÏ´Â indicator¶ó´Â Àǹ̷ΠsentinelÀ» ¹Þ¾Æµé¿´´Âµ¥ GTP°¡ ºñ½ÁÇÑ ´äÀ» Áá½À´Ï´Ù. Á¦¹Ì´Ïµµ µ¿ÀÏÇÑ ´äº¯À» ÇÏ´Â °Ô ¿©·¯°¡Áö·Î ³î¶ø³×¿ä. µ¿ÀÏÇÑ ·¹ÆÛ·±½º¸¦ ¾î¼±°¡ º¸°í ´äÇÏ´Â °ÍÀÌÁö. ±×·± Àǹ̿¡¼­ pubmed¿¡¼­ ãÀº esophagoramÀÇ À̹ÌÀÚ¿Í º¸Ãʰ¡ ¼­ÀÖ´Â ¸ð½ÀÀÇ À¯»ç¼º¿¡ ´ëÇØ¼­´Â AI°¡ ¾ð±ÞÀ» ¾ÈÇØÁá´Ù´Â °ÍÀÌ Æ¯Á¤ Àü¹®ºÐ¾ß¿¡¼­ Àü¹®°¡°¡ ³ª¸§ÀÇ ÅøÀ» »ç¿ëÇØ °Ë»öÇÏ´Â °ÍÀº ¿©ÀüÈ÷ Ãß°¡ÀûÀÎ, ȤÀº µ¶Æ¯ÇÑ Á¤º¸¸¦ ã¾Æ³¾ ¼ö ÀÖ´Â °Í °°¾Æ¼­ À§¾ÈÀÌ µÇ¾ú½À´Ï´Ù. AI¸¦ º¸Á¶ÀûÀ¸·Î Àß »ç¿ëÇϸ鼭 ÀüÅëÀûÀÎ °Ë»öÀ» ¿­½ÉÈ÷ ÇØ¾ß°Ú´Ù´Â »ý°¢ÀÌ µå³×¿ä.

[2025-3-6. ¾Öµ¶ÀÚ ´äº¯] ±³¼ö´Ô. À¯Æ©ºê ¿µ»óÀ» º¸´Ù°¡ ±Ã±ÝÇØ¼­ ã¾Æº¸¾Ò½À´Ï´Ù. Sentinel polypÀÇ ¾î¿ø¿¡ ´ëÇØ¼­ ¼³¸íÀÌ Àß µÇ¾î ÀÖ´Â °Í °°¾Æ¼­ ±³¼ö´Ô²²µµ °øÀ¯µå¸³´Ï´Ù. "Just as a sentinel is defined as a ¡°soldier or guard who job is to stand and keep watch¡± (Fig. 1) and medically as ¡°an indicator of the presence of disease¡± [4], the sentinel polyp and fold serve as indicators of hyperplastic polyps most commonly caused by gastroesophageal reflux resulting in esophagitis." (Abdominal Radiology 2021;46:2255) óÀ½ ¸í¸í ´ç½Ã¿¡ gastroesophageal reflux¿Í esophagitis¸¦ ³ªÅ¸³»´Â indicator ó·³ Sentinel polypÀÌ »ç¿ëµÇ¾ú´ø °Í °°½À´Ï´Ù.

2025-21. À§¼±Á¾À¸·Î ÀÇ·ÚµÈ È¯ÀÚ¿¡¼­ ¹ß°ßµÈ ´ëÀå¾Ï

2025-2-28

2025-20. Endoscopic findings of gastric MALToma. À§ MALT ¸²ÇÁÁ¾ ³»½Ã°æ ¼Ò°ß

2025-2-28

[2025-3-1. ¾Öµ¶ÀÚ Áú¹®] Polypoid type À¸·Î ¼Ò°³ÇØ ÁֽŠÁõ·Ê Áß ¼¼¹øÂ° Áõ·Ê´Â, À§Ä¡µµ ±×·¯Çϰí varix ¿Í °¨º°ÀÌ ¾î·Á¿ö¼­ Á¶Á÷°Ë»ç¸¦ Çϱ⿡ ¸Á¼³¿©Á³À» µí ÇÕ´Ï´Ù.. Á¶Á÷°Ë»ç Àü ct ¸¦ ½ÃÇàÇØ º¸´Â µîÀÇ ¹æ¹ýÀÌ µµ¿òÀÌ µÉÁö¿ä?

[2025-3-2. ÀÌÁØÇà ´äº¯] ¸Å¿ì ÁÁÀº Áú¹®ÀÔ´Ï´Ù. ¸»¾¸ÁֽŠ¹Ù¿Í °°ÀÌ fundusÀÇ À¶±âºÎ´Â gastric fundal varixÀÇ °¡´É¼ºÀ» °í·ÁÇÏ¿© Á¶Á÷°Ë»ç¸¦ Çϱâ Àü¿¡ Àá½Ã °í¹ÎÇØ º¸´Â °ÍÀÌ ÁÁ½À´Ï´Ù. Think twice. °£È¤ ÀÛÀº SMT¶ó°í »ý°¢Çϰí Á¶Á÷°Ë»ç ÇÑ ÈÄ ´ë·® ÃâÇ÷À» º¸ÀÎ °æ¿ì°¡ ÀÖ½À´Ï´Ù (¸ðµç SMT¸¦ óÀ½ ¹ß°ßÇÏ¿´À» ¶§ ²À Á¶Á÷°Ë»ç¸¦ ÇØ¾ß ÇÑ´Ù´Â °ÍÀº °ú°ÅÀÇ ÇêµÈ ÁÖÀåÀÔ´Ï´Ù. http://endotoday.com/endotoday/situation.html#biopsyÀÇ »óºÎÀ§Àå°ü Á¡¸·ÇÏÁ¾¾ç ºÎºÐ Âü°í). ±×·¯³ª ÀÌ È¯ÀÚ¿¡¼­´Â vascularÇÑ Æ¯¼ºÀÌ ÀüÇô ¾ø¾úÀ¸¸ç °ú°Åº¸´Ù Á¡Â÷ ÀÚ¶ó´Â ¾ç»óÀ¸·Î º¼ ¶§, °£ÁúȯÀÇ ¼Ò°ßÀÌ ÀüÇô ¾ø´Ù´Â °ÍÀ» °í·ÁÇÒ ¶§ gastric fundal varixÀÇ °¡´É¼ºÀº ³·¾Æ¼­ Á¶Á÷°Ë»ç¸¦ Çß´ø °Í °°½À´Ï´Ù. Á¶±ÝÀÌ¶óµµ gastric varix°¡ ÀǽɵǸé Ç÷¾×°Ë»ç¿Í CT¸¦ ¸ÕÀú ÇØ º¸´Â °ÍÀº ¾î¶²Áö ¹®ÀÇÇϽг»¿ë¿¡ µ¿ÀÇÇÕ´Ï´Ù.

2025-19. MALToma. MALT ¸²ÇÁÁ¾. 100% ¾ÏÀÌ¶óµµ µè°í ¿À¼Ì´ø ȯÀÚ¿¡ ´ëÇÏ¿©

2025-2-25.

[2025-2-25. ¾Öµ¶ÀÚ Áú¹®] Maltoma¿¡¼­ PET CT´Â ²À ÇÊ¿äÇÏ´Ù°í º¸½Ã´ÂÁö¿ä?

[2025-2-25. ÀÌÁØÇà ´äº¯] Á¦ ÀǰßÀº NoÀÔ´Ï´Ù. Diffuse large B cell lymphoma¿¡¼­´Â PET °Ë»ç¸¦ ÀÚÁÖ ½ÃÇàÇϰí ÀÖ½À´Ï´Ù. ±×·¯³ª gastric MALToma¿¡¼­ PETÀ» ½ÃÇàÇÏÁö ¾Ê½À´Ï´Ù. (1) ÇÊ¿äÇÏÁö ¾Ê½À´Ï´Ù. CT·Î Æò°¡Çϸé ÃæºÐÇÕ´Ï´Ù. (2) ½ÉÆòÀÇÇп¡¼­ PET/CT °Ë»ç ½ÃÇàÀ» Çã¿ëÇϰí ÀÖ´ÂÁö ¸ð¸£°Ú½À´Ï´Ù. °ú°Å¿¡´Â CT¿¡¼­ ¹º°¡ ÀÌ»ó ¼Ò°ßÀÌ ÀÖÀ¸¸é Ãß°¡·Î PET/CT¸¦ ÇÒ ¼ö ÀÖ´Â °ÍÀ¸·Î µÇ¾î ÀÖ¾ú½À´Ï´Ù. ÀÚ²Ù ¹Ù²î´Â °Í °°°í, ¾îÂ¥ÇÇ ÇÊ¿äÇÏÁö ¾Ê¾Æ¼­ ÇöÀç´Â ¾î¶»°Ô µÇ°í ÀÖ´ÂÁö Àß ¸ð¸£°Ú½À´Ï´Ù. Á˼ÛÇÕ´Ï´Ù. (3) NCCN 2025³â °¡À̵å¶óÀÎÀ» ´Ù½Ã ã¾Æº¸¾Ò½À´Ï´Ù. CT or PET/CT·Î µÇ¾î ÀÖ¾ú½À´Ï´Ù. CT¸¦ Çϸé PET/CT¸¦ ÇÒ ÀÌÀ¯°¡ ¾ø´Ù°í »ý°¢µË´Ï´Ù. ¿äÄÁµ¥ routineÇÏ°Ô °Ë»çÇÏ´Â °ÍÀº ±ÇÇÏÁö ¾Ê°í CT À¯¼Ò°ßÀ̳ª ±âŸ ´Ù¸¥ ÀÌÀ¯°¡ ÀÖÀ» ¶§¿¡ ÇÑÇÏ¿© selectiveÇÏ°Ô PET/CT¸¦ Çϰí ÀÖ½À´Ï´Ù. (»ç½Ç °ÅÀÇ ÇÏÁö ¾ÊÀ½)

2025 NCCN guideline

[2025-2-26. YouTube Áú¹®]

±³¼ö´Ô²²¼­´Â ´ëÀå³»½Ã°æ ÁøÇà ½Ã¿¡µµ ¹Ì´ÙÁ¹¶÷¸¸ »ç¿ëÇϽô °Ç°¡¿ä? ÇÁ·ÎÆ÷Æú º´ÇÕ¿ä¹ý ¾øÀÌ..? ±×·³ ¹Ì´ÙÁ¹¶÷+ÆäÄ¡µò »ç¿ëÇϽô °É±î¿ä? ¹Ì´ÙÁ¹¶÷¸¸ »ç¿ëÇϸé ȯÀںР°íÅë ¹®Á¦°¡ ÀÖÁö ¾Ê¾Æ ½Í¾î¼­¿ä

[2025-2-27. ÀÌÁØÇà ´äº¯]

ÁÁÀº Áú¹® °¨»çÇÕ´Ï´Ù. Àú´Â ´ëÀå³»½Ã°æ¿¡¼­ ¹Ì´ÙÁ¹¶÷°ú ÆäÄ¡µòÀ» ÇÔ²² »ç¿ëÇϰí ÀÖ½À´Ï´Ù. À§³»½Ã°æ¿¡¼­´Â ÆäÄ¡µòÀ» »ç¿ëÇÏÁö ¾Ê´Â °æ¿ìµµ ¸¹Áö¸¸ ´ëÀå³»½Ã°æ¿¡¼­´Â ¾Æ¹«·¡µµ ÅëÁõ ¿ì·Á°¡ À־ ´ëºÎºÐ ÆäÄ¡µòÀ» »ç¿ëÇϰí ÀÖ½À´Ï´Ù.

¿©·¯ ÀÇ·á ȯ°æ¿¡¼­ À§³»½Ã°æÀ̳ª ´ëÀå³»½Ã°æ °úÁ¤¿¡¼­ ÇÁ·ÎÆ÷ÆúÀÌ À¯¿ëÇÏ°Ô »ç¿ëµÇ°í ÀÖ´Â °ÍÀº Àß ¾Ë°í ÀÖ½À´Ï´Ù. ¹Ì´ÙÁ¹¶÷°ú ÇÁ·ÎÆ÷Æú º´ÇÕ¿ä¹ýµµ ¹«Ã´ ¸Å·ÂÀûÀÔ´Ï´Ù. ±×·¯³ª Á¦°¡ ±Ù¹«Çϴ ȯ°æÀÌ ±³À°º´¿øÀÎ °ü°è·Î ȯÀÚÀÇ ÆíÀÇ¿Í ÇÔ²² ȯÀÚÀÇ ¾ÈÀüµµ ³õÄ¥ ¼ö ¾ø´Â ¸ñÇ¥ÀÔ´Ï´Ù. ÇâÈÄ º¯°æÀ» °í·ÁÇϰí ÀÖ½À´Ï´Ù¸¸, ¾ÆÁ÷±îÁö´Â ÇÁ·ÎÆ÷ÆúÀº ¸¶Ãë°¡ Àǻ縸 ¾²µµ·Ï Çϰí ÀÖ½À´Ï´Ù. ESD µî Ä¡·á³»½Ã°æ¿¡¼­´Â ¸¶Ãë°ú Àǻ縦 ¸ð¼Å¼­ ÇÁ·ÎÆ÷Æú µî ´Ù¾çÇÑ ¾àÁ¦¸¦ »ç¿ëÇÒ ¼ö ÀÖÁö¸¸, ÀÏ´Ü Áø´Ü³»½Ã°æÀ̳ª ´ëÀå ¿ëÁ¾ÀýÁ¦¼ú µî¿¡¼­´Â ¹Ì´ÙÁ¹¶÷°ú ÆäÄ¡µòÀ» ¾²°í ÀÖ½À´Ï´Ù. ´ë°­ÀÇ ¿ë·®À» Á¤Çسõ°í (http://endotoday.com/endotoday03/20220804_03.jpg) ȯÀÚ»óÅ¿¡ µû¶ó¼­ °¡°¨ÇÏ¿© Àû¿ëÇϰí ÀÖ½À´Ï´Ù.

2025-18. À¯¹®¼± ¼±Á¾. Pyloric gland adenoma

2025-2-17.

[2025-2-18. ÀÌÁØÇà] ¾ÆÁÖ Æ¯º°ÇÑ °­ÀÇ ¿µ»óÀÔ´Ï´Ù. ¸çÄ¥ Àü ´ÚÅͺô¿¡¼­ °­ÀǸ¦ ÇßÀ» ¶§ ÇÑ ºÐ²²¼­ Áú¹®À» Áּ̽À´Ï´Ù. °­ÀÇ ÈÄ Q and A ¿´À¸¹Ç·Î °£´ÜÈ÷ ´äÇÏ¿´½À´Ù. ´ÙÀ½ ³¯ ³»½Ã°æ »çÁø°ú ÇÔ²² ¸ÞÀÏ·Î »ó¼¼ÇÑ Áú¹®ÀÌ µµÂøÇÏ¿´½À´Ï´Ù. Àúµµ ¸ÞÀϷΠª°Ô ´äÇÏ¿´Áö¸¸ ¾Æ¹«·¡µµ ºÎÁ·ÇÑ °Í °°¾Æ µ¿¿µ»óÀ» ¸¸µé¾ú½À´Ï´Ù.

[2025-2-14. ¾Öµ¶ÀÚ Áú¹®] ±³¼ö´Ô. ¾È³çÇϽʴϱî. ¾îÁ¦ ´ÚÅͺô¿¡¼­ pyloric gland adenoma·Î Áú¹® µå·È´ø XXXÀÔ´Ï´Ù. °í·ÉÀÇ ¿©ÀÚºÐÀ̼̰í fundus¿Í upper body¿¡ °ÉÃÄ 4~5cm °¡·®ÀÇ mass-like elevated lesionÀ̾ú°í ¹ßÀû¼º Á¡¸· º¯È­¿Í ÀϺδ µÎ²¨¿öÁø Á¡¸· º¯È­¸¦ º¸ÀÌ¸ç °âÀÚ¿¡ Á¶Á÷ÀÌ ¹¶ÅÖÀÌ·Î ºÎ½º·¯ÁöµíÀÌ ¶³¾îÁö´Â ¾ç»ó¿¡ antrum¿¡ ºñÇÏ¿© body¿Í fundusÀÇ À§Ã༺ º¯È­°¡ ÇöÀúÇÑ ¼Ò°ßÀ̾ú½À´Ï´Ù. Á¶Á÷ °Ë»ç¿¡¼­´Â focal HGD·Î È®ÀεǾú°í Áö¿ª°ÅÁ¡ ´ëÇÐ º´¿ø¿¡¼­ ¼ö¼úÀ» ±ÇÀ¯ ¹Þ¾Ò½À´Ï´Ù. ÀÌÁ¦±îÁö ºÃ´ø ¾Ïµé°ú´Â »ó´çÈ÷ ´Ù¸¥ ¸ð½ÀÀ̶ó°í »ý°¢µÇ¾ú´ø º´º¯À̶ó Áú¹®À» µå·Áº¸¾Ò°í Ưº°ÇÏÁö´Â ¾Ê´Ù´Â ±³¼ö´ÔÀÇ ´äº¯À» µè°í, ¿£µµÅõµ¥À̵µ ÇÑ ¹ø ´õ ã¾Æº¸¾Ò½À´Ï´Ù. ¿ÃÇØµµ °Ç°­ÇϽðí, Ç×»ó ÁÁÀº °¡¸£Ä§À» ÁÖ°í °è¼Å¼­ ´Ã °¨»çÇϰí ÀÖ½À´Ï´Ù.

[2025-4-14. ÀÌÁØÇà ´äº¯] ¿¹. Àúµµ Á» ´õ È®ÀÎÇÏ¿© update ÇϰڽÀ´Ï´Ù. 1. ÀϹÝÀûÀ¸·Î adenomaÀÇ subtype¿¡ µû¸¥ Ä¡·á ¿øÄ¢ÀÇ Â÷ÀÌ´Â ¾ø½À´Ï´Ù. 2. ¾ÏÀÌ ¾Æ´Ñ ÀÌ»ó ¼ö¼úº¸´Ù´Â ºñ·Ï incomplete resectionÀÌ¶óµµ ³»½Ã°æÀ¸·Î ¾î¶»°Ô ÇØ º¸´Â °ÍÀ» ÁÁ¾ÆÇÏ´Â ºÐµéµµ °è½Ê´Ï´Ù. °¨»çÇÕ´Ï´Ù.

[2025-2-17. ¾Öµ¶ÀÚ²²¼­ °­ÀÇ ¿µ»óÀ» º¸½Å ÈÄ ÁֽŠ´ñ±Û] ±³¼ö´Ô. Áú¹® µå·È´ø ¾Öµ¶ÀÚÀÔ´Ï´Ù. »ç¼ÒÇÑ Áú¹®ÀÏÅÙµ¥ ÀÌ·¸°Ô »¡¸® Çǵå¹é ÇØ Áּż­ °¨»ç µå¸³´Ï´Ù. ¸¹Àº °øºÎ°¡ µÇ¾ú½À´Ï´Ù.

2025-17. ³»½Ã°æ Áõ·Ê¸¦ ÅëÇØ È®ÀÎÇÏ´Â ¾Ë½ö´Þ½ö Q&A 8ź

2025-2-13. log-in é©

2025-16. EUS for EGC. EUS´Â ESD Àü ħÀ±±íÀÌ Æò°¡¿¡ µµ¿òÀÌ µÇ´Â°¡

2025-2-12.

2025-15. Ç︮ÄÚ¹ÚÅÍ °­ÀǸ¦ µè°í. Helicobacter Á¦±ÕÄ¡·á °­ÀǸ¦ µè°í ´À³¤ Á¡ µÎ °¡Áö

2025-2-11.

2025-14. µÚ´Ê°Ô ¹ß°ßµÈ À§¾Ï ´ëÀåÀüÀÌ. Colonic metastasis from gastric cancer

2025-2-10.

2025-13. Æó¾Ï À§ÀüÀÌ. Gastric metastasis from lung cancer

2025-2-9.

2025-12. ³¯¹® ±Ë¾ç. Pyloric ring ulcer

2025-2-5.

2025-11. ¹ÌºÐÈ­ Á¶Á÷Çü Á¶±âÀ§¾Ï ³»½Ã°æ Ä¡·á. ESD for EGC with undifferentiated type histology

2025-2-3.

[2025-2-3. ¾Öµ¶ÀÚ Áú¹®] ±³¼ö´Ô Ç×»ó °­ÀÇ Àß µè°íÀÖ½À´Ï´Ù. ÇѰ¡Áö Áú¹®ÀÌ ÀÖ½À´Ï´Ù. LN2°³ ¹Ì¸¸Àΰæ¿ì´Â ¼ö¼úÀ» ÇÏ´õ¶óµµ Ç×¾Ï ¾øÀÌ Obsevation¾Æ´ÑÁö¿ä? ÀÌ °æ¿ì¿¡¼­µµ ¼ö¼ú°ú ESD°¡ »ýÁ¸·ü Â÷À̰¡ ÀÖÀ» °ÍÀ̶ó°í ¿¹»óÇϽôÂÁö¿ä?

[2025-2-3. ÀÌÁØÇà ´äº¯] ÁÁÀº Áú¹® °¨»çÇÕ´Ï´Ù.

1) À§¾Ï ¼ö¼ú ÈÄ º¸Á¶Ç×¾ÏÄ¡·á´Â ¸²ÇÁÀý ÀüÀÌ ¿©ºÎ·Î °áÁ¤ÇÏ´Â °ÍÀÌ ¾Æ´Ï°í stagingÀ¸·Î °áÁ¤ÇÕ´Ï´Ù. 2±â À̻󿡼­ º¸Á¶Ç×¾ÏÄ¡·á¸¦ ÇÕ´Ï´Ù. ¿¹¸¦ µé¾î, AJCC 7ÆÇÀ¸·Î Á¡¸·¾ÏÀÌ°í ¸²ÇÁÀýÀÌ 2°³ ¾ç¼ºÀ̶ó¸é T1a, N1À̰í stage 1bÀÔ´Ï´Ù. º¸Á¶Ç×¾ÏÄ¡·á¸¦ ÇÏÁö ¾Ê½À´Ï´Ù. Subserosa¾ÏÀÌ°í ¸²ÇÁÀý ÀüÀ̰¡ ¾ø´Ù¸é T3, N0À̰í stage 2aÀÔ´Ï´Ù. º¸Á¶Ç×¾ÏÄ¡·á¸¦ ÇÕ´Ï´Ù. ¸²ÇÁÀý ÀüÀÌ ¿©ºÎ·Î Ç×¾ÏÄ¡·á¸¦ ÇÏÁö ¾Ê°í depth of invasion°ú ¸²ÇÁÀý ÀüÀ̸¦ ¸ðµÎ °í·ÁÇÏ¿© °áÁ¤ÇÑ´Ù°í »ý°¢ÇϽñ⠹ٶø´Ï´Ù. Á¡¸·ÇϾÏÀÌ°í ¸²ÇÁÀýÀÌ 2°³ ¾ç¼ºÀ̶ó¸é T1b, N1À̰í stage 1bÀÔ´Ï´Ù. ÀÌ·± ȯÀÚ Áß ³ª¸§´ë·Î °øºÎÇÏ°í ¿©±â Àú±â ¾Ë¾Æº» ÈÄ º¸Á¶Ç׾Ͽä¹ýÀ» ¹Þ°í ½Í´Ù°í ã¾Æ¿À´Â °æ¿ì°¡ ÀÖ½À´Ï´Ù. ±×·±µ¥ stage 1b¿¡¼­ º¸Á¶Ç׾Ͽä¹ýÀ» Åõ¾àÇÒ ¼ö ÀÖ´Â ¹æ¹ýÀÌ ¾ø½À´Ï´Ù. ½ÉÆòÀÇÇÐ °øÈ­±¹ÀÎ ¿ì¸®³ª¶ó¿¡¼­´Â ºÒ°¡´ÉÇÕ´Ï´Ù. ¿¹¿Ü´Â ¾ø½À´Ï´Ù. ¿Ü±¹¿¡ °¡¼Å¾ß ÇÕ´Ï´Ù.

2) "ÀÌ °æ¿ì¿¡¼­µµ ¼ö¼ú°ú ESD°¡ »ýÁ¸À² Â÷À̰¡ ÀÖÀ» °ÍÀ̶ó°í ¿¹»óÇϽôÂÁö¿ä?" ºÎºÐÀº Á¶±Ý trickyÇÑ Áú¹®ÀÔ´Ï´Ù. Á¶±âÀ§¾ÏÀÌ°í ¸²ÇÁÀý ÀüÀ̰¡ 1-2°³ÀΠȯÀÚ°¡ ¼ö¼úÀ» ¹Þ¾Ò´Ù¸é R0 resectionÀ̰í stage 1bÀ̹ǷΠº¸Á¶Ç׾Ͽä¹ý ¾øÀÌ Àå±â »ýÁ¸À» ±â´ëÇÒ ¼ö ÀÖ½À´Ï´Ù. ±×·±µ¥ ÀÌ È¯ÀÚ°¡ ESD¸¦ ¹Þ¾Ò´Ù¸é stomach wallÀÇ local controlÀº µÇ¾ú´õ¶óµµ ¸²ÇÁÀý ÀüÀÌ´Â ±×´ë·Î ³ö µÎ´Â °ÍÀÔ´Ï´Ù. R1 ¶Ç´Â R2 resectionÀÔ´Ï´Ù. ¾ÆÁ÷ ÀýÁ¦°¡ ´Ù µÈ °ÍÀÌ ¾Æ´Õ´Ï´Ù. Àå±âÀûÀ¸·Î º¸´Ù Å« ÀüÀ̸¦ ÀÏÀ¸Å³ °ÍÀÔ´Ï´Ù. Complete resectionÀÌ µÈ ÈÄ Àç¹ßÀ» °ÆÁ¤ÇÏ´Â °Í(¼ö¼ú)°ú óÀ½ºÎÅÍ ¾Æ¿¹ complete resectionÀÌ µÇÁö ¸øÇϰí ÀüÀÌ ¸²ÇÁÀýÀÌ ³²ÀÌÀÖ´Â °Í(ESD)Àº ÀüÇô ´Ù¸¥ »óȲÀÔ´Ï´Ù. º¸Á¶Ç׾Ͽä¹ýÀ» ÇÏ´À³Ä ÇÏÁö ¾Ê´À³Ä¿Í ESD ÀûÀÀÁõÀÌ³Ä ¾Æ´Ï³Ä´Â ÀüÇô ´Ù¸¥ ¹üÁÖÀÔ´Ï´Ù.


[2025-2-3. ¾Öµ¶ÀÚ Áú¹®] pathology¿¡¼­ awd with apd °°Àº º´¸® º¸°í¸¦ Áֽô °æ¿ì°¡ Àִµ¥ ÀÌ·¯ÇÑ °æ¿ì¿¡´Â ºÐÈ­¾Ï°ú ¹ÌºÐÈ­¾Ï ¾î¶»°Ô ±¸ºÐÇØ¼­ Ä¡·á ¹æÇâÀ» °áÁ¤ÇÏ¿©¾ß Çϳª¿ä? (AWD with pcc component 20% °°Àº ºÐÈ­¾Ï°ú ¹ÌºÐÈ­¾ÏÀ» °°ÀÌ Àû¾îÁÖ´Â °æ¿ì)

[2025-2-3. ÀÌÁØÇà ´äº¯] Adenocarcinoma, well differentiated with poorly cohesive carcinoma 20%¿Í °°Àº º´¸® ¼Ò°ßÀº È¥ÀçÇü (mixed type)À¸·Î º¸°í ÀÖ½À´Ï´Ù. ¿¹ÈÄ´Â ºÐÈ­ Á¶Á÷Çü > ¹ÌºÐÈ­ Á¶Á÷Çü > È¥ÀçÇüÀ̶ó´Â Áï È¥ÀçÇüÀÌ °¡Àå ³ª»Ú´Ù´Â °ÍÀÌ ÀϹÝÀûÀÎ °ßÇØÀÔ´Ï´Ù. ¸î % ÀÌ»óÀÌ È¥ÀçÇüÀÎÁö Á¤Àǰ¡ ¾ø°í, È¥ÀçÇü¿¡ ´ëÇÑ ESD ÀûÀÀÁõÀÌ È®¸³µÇ¾î ÀÖÁö ¾ÊÀ¸¹Ç·Î º¸Åë ¹ÌºÐÈ­ Á¶Á÷Çü¿¡ ÁØÇÏ¿© Ä¡·á¹ýÀ» ¼±ÅÃÇϰí ÀÖ½À´Ï´Ù. Àü¹®°¡¿¡ µû¶ó¼­ 5% ÀÌÇÏÀÇ ¹ÌºÐÈ­ Á¶Á÷Çü component´Â ¹«½ÃÇϱ⵵ ÇÕ´Ï´Ù. Àú´Â ³»½Ã°æ ¼Ò°ß°ú º´¸® ¼Ò°ßÀ» ¸ðµÎ Àç°ËÅäÇÕ´Ï´Ù. ½Ã´ë°¡ ¹Ù²î°í ÀÖ½À´Ï´Ù. Digital pathology°¡ º¸±ÞµÇ°í ÀÖ½À´Ï´Ù. ÀÌÁ¦´Â ³»½Ã°æ Àǻ絵 º´¸®Àǻ簡 ½á ÁØ °á°ú¸¦ text·Î¸¸ º¼ °ÍÀÌ ¾Æ´Ï°í ¾Ö¸ÅÇϸé Á÷Á¢ º´¸® »çÁøÀ» º¸´Â °ÍÀÌ ÁÁ´Ù°í »ý°¢ÇÕ´Ï´Ù. Á÷Á¢ º´¸® ½½¶óÀ̵带 º¼ ¼ö ÀÖ´Â digital pathology ȯ°æÀÌ ¾Æ´Ï¶ó¸é, ´ë½Å º´¸®°ú Àǻ翡°Ô ÀüÈ­ÇØ º¸½Ç °ÍÀ» ±ÇÇÕ´Ï´Ù. Text¿¡ ¾ø´Â À̾߱⸦ µè°Ô µÇ´Â °æ¿ìµµ ÀûÁö ¾Ê½À´Ï´Ù.

2025-10. Metachronous cancer after ESD for cardia EGC

2025-1-31.

2025-9. ¼ÒÈ­¼º ±Ë¾ç ÃßÀû³»½Ã°æ¿¡¼­ PPI¸¦ Áß´ÜÇØ¾ß Çϴ°¡?

2025-1-27.

2025-8. Amebic colitis. ¾Æ¸¶º£ Àå¿°

2025-1-24.

2025-7. Bleeding peptic ulcer case discussion. ¼ÒÈ­¼º ±Ë¾ç ÃâÇ÷ Áõ·Ê ÅäÀÇ.

2025-1-23.

[2025-1-26. ¾Öµ¶ÀÚ Áú¹®] Alcoholics case ¿¡¼­ PPI¸¦ À¯ÁöÇÑ »óÅ·Π³»½Ã°æ Àç°ËÀ» ½ÃÇàÇϽеí Çѵ¥, CLO µî Ç︮ÄÚ¹ÚÅÍ °Ë»çÀÇ À§À½¼º °¡´É¼ºÀº ¾øÀ»Áö¿ä?

[2025-1-26. EndoTODAY ´äº¯] ÁÁÀº Áú¹® °¨»çÇÕ´Ï´Ù. Áõ·Ê¿¡¼­´Â ÀÏ´Ü ÁöÇ÷¼ú ÈÄ Áï½Ã Ç︮ÄÚ¹ÚÅÍ °Ë»ç¸¦ ÇÏ¿´½À´Ï´Ù. ´ç½Ã´Â Giemsa À½¼ºÀ̾ú½À´Ï´Ù. ¹°·Ð ÃâÇ÷ »óȲ¿¡¼­ Ç︮ÄÚ¹ÚÅÍ Á¶Á÷°Ë»çÀÇ ¾ç¼º·üÀÌ Á¶±Ý ³·À» ¼ö ÀÖ´Ù´Â Á¡Àº ÀÌÇØÇϰí ÀÖ½À´Ï´Ù. Helicobacter ¾ç¼ºÀÏ °ÍÀ¸·Î ¿¹»óµÇ´Â »óȲ¿¡¼­ À½¼ºÀÌ ³ª¿ÔÀ¸¹Ç·Î ÃßÀû°Ë»ç¿¡¼­µµ Ç︮ÄÚ¹ÚÅÍ °Ë»ç¸¦ ÇÏ´Â °ÍÀÌ ÁÁÀº »óȲÀ̾ú½À´Ï´Ù. PPI¸¦ 4ÁÖ Ã³¹æÇϰí 3ÁÖ ÈÄ ³»½Ã°æ °Ë»ç¸¦ ÇÏ¿´À¸¹Ç·Î Áú¹®ÁֽŠ¹Ù¿Í °°ÀÌ PPI¸¦ À¯ÁöÇÑ »óÅ·Π³»½Ã°æ Àç°ËÀ» ÇÑ °ÍÀº ¸Â½À´Ï´Ù. Àúµµ ¼ÒÈ­¼º±Ë¾ç ȯÀÚÀÇ ÃßÀû°Ë»ç¿¡¼­ PPI¸¦ 2ÁÖ Áß´ÜÇÏ°í ³»½Ã°æÀ» Çϸ鼭 Ç︮ÄÚ¹ÚÅÍ °Ë»ç¸¦ ÇÕ´Ï´Ù. ±×·¯³ª °íÀ§Çè ÃâÇ÷ ȯÀÚ¿¡¼­, ƯÈ÷ ¸¸¼º ÁúȯÀÌ Àְųª NSAIDs³ª ¼úÀ» ²÷Áö ¾ÊÀº ȯÀÚ¿¡¼­ PPI Áß´Ü ÈÄ ³»½Ã°æ °Ë»ç¸¦ Çϱâ Àü 1-2ÁÖ »çÀÌ¿¡ ÀçÃâÇ÷À» ÇÏ´Â °æ¿ì¸¦ °æÇèÇÑ ¹Ù ÀÖ½À´Ï´Ù. ÀÌ·± À§ÇèÀÌ ÀÖ´Â °æ¿ì¿¡´Â Ç︮ÄÚ¹ÚÅÍ °Ë»çÀÇ Á¤È®µµ°¡ ´Ù¼Ò ³·¾ÆÁö´Â °ÍÀ» °¨¼öÇÏ´õ¶óµµ on PPI »óÅ¿¡¼­ ³»½Ã°æ °Ë»ç¸¦ Çϰí ÀÖ½À´Ï´Ù. Ç︮ÄÚ¹ÚÅÍ´Â ÃßÈÄ ¾ðÁ¦µçÁö °Ë»çÇÒ ¼ö Àֱ⠶§¹®ÀÔ´Ï´Ù. "ÀÌ·¯Àú·¯ÇÑ ÀÌÀ¯·Î Ç︮ÄÚ¹ÚÅÍ °Ë»ç¸¦ ÃæºÐÈ÷ ÇÒ ¼ö ¾ø¾úÀ¸´Ï ÀÌÁ¦ Ç︮ÄÚ¹ÚÅÍ °Ë»ç¸¦ ÇØ º¾½Ã´Ù"¶ó°í ¸»ÇÒ ±âȸ´Â ¸¹½À´Ï´Ù. UBT¸¦ ÇÏ¸é µË´Ï´Ù. Ç︮ÄÚ¹ÚÅÍ Á¦±ÕÄ¡·á ÈĶó¸é ÀÏ¹Ý º¸Çè ±Þ¿©, Ç︮ÄÚ¹ÚÅÍ Á¦±ÕÄ¡·á¸¦ ÇÏÁö ¾Ê¾Ò´ø ȯÀÚ¿¡¼­´Â ºñ±Þ¿©ÀÔ´Ï´Ù.

[2025-1-26. ¾Öµ¶ÀÚ Áú¹®] ¸»¾¸ÁֽŠ»óȲ¿¡¼­ serology ¸¦ °í·ÁÇØ º¸´Â°ÍÀº ´ë¾ÈÀÌ µÉ ¼ö ÀÖÀ»±î¿ä?

[2025-1-27. EndoTODAY ´äº¯] ¿¹. UBT°¡ ¾î·Á¿ï »óȲ¿¡¼­´Â serologyµµ °¡´ÉÇÒ °ÍÀ¸·Î ÆÇ´ÜµË´Ï´Ù.

2025-6. Exophytic SET at antrum¿¡ ´ëÇÑ Áú¹®¿¡ ´äÇÕ´Ï´Ù.

2025-1-19.

2025-5. Depth of invasion of a small depressed lesion with focal wall thickening. Á¶±âÀ§¾ÏÀΰ¡ ÁøÇ༺ À§¾ÏÀΰ¡?

2025-1-15. ECR

2025-4. AGC B-IV. º¸¸¸ 4Çü ÁøÇ༺ À§¾Ï

2025-1-10. ECR

2025-3. DEX 2 Áú¹®¿¡ ´äÇÔ

2025-1-9.

2025-2. Friability

2025-1-6.

2025-1. Fundus º´¼Ò À§Ä¡ Ç¥½Ã¹ý

2025-1-2.

[¾Öµ¶ÀÚ ÆíÁö]

±³¼ö´Ô »õÇØº¹¸¹À̹ÞÀ¸½Ê½Ã°í »õÇØ´Â ´õ´õ °Ç°­ÇϽʽÿÀ. Áõ·Ê2ÀÇ HP(-) fundic gland adenocarcinoma°¡ ¹Ý°©³×¿ä. ÀϺ» NTT °ßÇÐÇÒ¶§ HP(-) raspberry-like gastric fovelor type adenocarcimoma¸¦ EMR-C·Î ½Ã¼úÇÏ´Â °ÍÀ» ÀÚÁÖ º¸¾Ò´Âµ¥¿ä. ´Ù¹ß¼º À§Àú¼± ¿ëÁ¾È¯ÀÚ¿¡¼­ ¶óÁ¸®¸ð¾çÀÇ ¿ëÁ¾Àº ¾ø´ÂÁö ²Ä²ÄÈ÷ È®ÀÎÇÏ¿© ÀÚÁÖ ¹ß°ßÇÏ´Â °ÍÀ» º¸°í ³î¶ú´ø ±â¾ïÀÌ ÀÖ½À´Ï´Ù.


[2024]

2024-29. À§°¢. Gastric angle

2025-12-30.

2024-28. ³¯¹® À§¾Ï. Pyloric ring cancer

ECR 022. 2024-12-26.

2024-27. Description exercise ¿¹Á¦ 4¹®Á¦ ÇØ¼³

2024-12-20.

¿ì¸®³ª¶ó¿¡¼­ ³»½Ã°æÀ» ¹è¿ì´Â °ÍÀº ¹«Ã´ ¾î·Á¿î ÀÏÀÔ´Ï´Ù. Áú ÁÁÀº curriculumÀÌ ¸¹Áö ¾Ê±â ¶§¹®ÀÔ´Ï´Ù. °¡Àå Ç¥ÁØÀûÀÎ curriculumÀº ÀÎÅÏ 1³â, ³»°ú Àü°øÀÇ 3³â ÈÄ ¼ÒÈ­±â³»°ú fellow 2³âÀ» ÇÏ´Â °ÍÀÌÁö¸¸ ¸ðµç ºÐµé¿¡°Ô ÀÌ °úÁ¤ÀÌ ¿­·ÁÀÖ´Â °Íµµ ¾Æ´Õ´Ï´Ù. °Ô´Ù°¡ 2024³â 2¿ù ºÒ°ÅÁø ÀÇÁ¤»çÅ·ΠÀÎÇÏ¿© ¾î·Æ°Ô ¿î¿µµÇ´ø ¸¹Àº °úÁ¤µéÀÌ Áß´ÜµÈ °Íµµ ¾ÈŸ±î¿î ÀÏÀÔ´Ï´Ù. ¿ÀÈ£ÅëÀç¶ó...

Á¦°¡ ÀϺ»¿¡¼­ ESD¸¦ ¹è¿ï ¶§ Á¦¹ý ¸¹Àº ÀϺ» ³»½Ã°æ½ÇÀ» ¹æ¹®ÇÑ ÀûÀÌ ÀÖ½À´Ï´Ù. ´ç½Ã ³î¶ú´ø Á¡Àº ³»½Ã°æ½Ç¿¡ ÀÇ»çµéÀÌ ¸Å¿ì ¸¹´Ù´Â Á¡À̾ú½À´Ï´Ù. ¿ì¸®³ª¶ó¿¡¼­´Â °£È£»ç°¡ assist¸¦ ÇÏ´Â °æ¿ì°¡ ¸¹Áö¸¸ ÀϺ»¿¡¼­´Â ÀþÀº ÀÇ»çµéÀÌ assist¸¦ ÇÕ´Ï´Ù. ³»½Ã°æ Áغñµµ Çϰí, Á¶Á÷ °âÀÚµµ Àâ°í, ESD¸¦ ÇÒ ¶§ ¿·¿¡¼­ ÀÌ·± Àú·± °ÍÀ» µ½½À´Ï´Ù. ÀÌ °úÁ¤À» ÅëÇÏ¿© ºñ·Ï ÀÚ½ÅÀÌ Á÷Á¢ ³»½Ã°æÀ» ÇØ º» ÀûÀº ¾øÀ¸³ª ¼±»ý´ÔÀÇ ½Ã¼úÀ» ¼ö½Ê¹ø ¼ö¹é¹ø º¸¸é¼­ ¸ðµç »óȲ¿¡ Àͼ÷ÇØÁý´Ï´Ù. ±×¸®°í 1³â Âë ÈÄ Ã³À½ ³»½Ã°æÀ» Àâ°Ô µÇ´Âµ¥ ÀÌ¹Ì ´«À¸·Î, ¸Ó¸®·Î ¸ðµÎ ÀÍÈù »óȲÀ̹ǷΠ¼ú±â¸¦ ±Ý¹æ ¹è¿ì´Â °ÍÀ» º¸¾Ò½À´Ï´Ù. Âü ºÎ·¯¿î ±¤°æÀÌ ¾Æ´Ò ¼ö ¾ø½À´Ï´Ù.

Àú´Â ¿ì¸®³ª¶ó¿¡¼­ ±×·¡µµ ³»½Ã°æ °Ë»ç¸¦ ¸¹ÀÌ Çß´ø ¼ÒÀ§ ³»½Ã°æ Àü¹®°¡ÀÔ´Ï´Ù. ±×·±µ¥ ´Ã È¥ÀÚÀÔ´Ï´Ù. µµ¹«Áö º¸·¯ ¿À´Â »ç¶÷ÀÌ ¾ø½À´Ï´Ù. ¾î¼´Ù fellowµéÀÌ Àá½Ã ±â¿ô°Å¸®´Â °æ¿ì°¡ ÀÖÁö¸¸ º¸ÅëÀº È¥ÀÚÀÔ´Ï´Ù. °¡¸£Ä¡°í ½Í¾îµµ ¹è¿ì·¯ ¿À´Â »ç¶÷ÀÌ ¾ø½À´Ï´Ù. ÀϺ»¿¡¼­´Â Àú¿Í ºñ½ÁÇÑ °æ·ÂÀ» °¡Áø ³»½Ã°æ ¼±»ýÀÌ ½Ã¼úÀ» Çϸé ÀÌ º´¿ø Àú º´¿ø¿¡¼­ ¸¹Àº ºÐµéÀÌ Ã£¾Æ¿Í observationÀ» ÇÕ´Ï´Ù. ¼Ò¼Ó ±â°ü¿¡¼­ º¸³»´Â °æ¿ì´Â °ÅÀÇ ¾ø´Â °Í °°°í ½º½º·Î °³ÀÎ ÈÞ°¡¸¦ ³»¼­ ¼±»ýÀ» ã¾Æ´Ù´Ï´Â °ÍÀ̶ó°í ÇÕ´Ï´Ù. ÀÌ·¯ÇÑ °úÁ¤À» ÅëÇÏ¿© ¼ÒÀ§ ³»½Ã°æ °í¼öµéÀÇ ¼ú±â¸¦ º¸°í °í¼öµé°ú À̾߱⸦ Çϸ鼭 ½º½º·ÎÀÇ ½Ç·ÂÀ» Ű¿ì´Â °ÍÀÔ´Ï´Ù.

¿ì¸®³ª¶ó¿¡¼­µµ ³»½Ã°æÀ» ÇÏ´Â ºÐµéÀÌ ´Ù¸¥ º´¿øÀÇ ³»½Ã°æ ½Ã¼úÀ» ¸¹ÀÌ Âü°üÇÏ´Â ¹®È­°¡ µÇ¾úÀ¸¸é ÁÁ°Ú½À´Ï´Ù. °³ÀÎ ÈÞ°¡¸¦ ¾²½Ê½Ã¿À. ÈÞ°¡³»¼­ °æÇèÀÌ ¸¹Àº ¼±»ý´Ôµé ã¾Æ°¡ observationÀ» ÇϽʽÿÀ. ±×·¡¾ß ½Ç·ÂÀÌ ´ÃÁö ¾Ê°Ú½À´Ï´Ù. ¼ú±â´Â È¥ÀÚ ²þ²þ´í´Ù°í Çâ»óµÇ´Â °ÍÀÌ ¾Æ´Õ´Ï´Ù. °³ÀÎ ÈÞ°¡¸¦ ¾²½Ê½Ã¿À. ±³À°¿¡ ÀλöÇÑ ¿ì¸®³ª¶ó¿¡¼­ Á¶Á÷ÀÌ ³ª¸¦ À§ÇØ ±³À° ±âȸ¸¦ ÁÙ °ÍÀ» ±â´ëÇÏÁö ¸¶½Ê½Ã¿À. °³ÀÎ ÈÞ°¡¸¦ ³»°í °í¼öµéÀ» ã¾Æ´Ù´Ï´Â °ÍÀÌ À¯ÀÏÇÑ ÇØ¹ýÀÔ´Ï´Ù. ¿Ö ¸ÀÁý tour´Â Çϸ鼭 ³»½Ã°æ½Ç tour´Â ÇÏÁö ¾Ê´Â °ÍÀԴϱî? µÎµå¸®½Ê½Ã¿À.

2024-26. ÀÚ°¡¸é¿ªÀ§¿°. Autoimmune gastritis.

ECR 021. 2024-12-3.

2024-26. EGC IIa 5.5cm near cardia

ECR 020. 2024-12-2.

2024-25. º¸¸¸ 4Çü ÁøÇ༺ À§¾ÏÀÇ ³­¼Ò ÀüÀÌ

ECR 019. 2024-11-27.

2024-24. Hyperplastic polyp

ECR 018. 2024-11-25.

2024-23. Submucosal invasion in forceps biopsy + Lecture dropout

ECR 017. 2024-11-7.

2024-22. ESD for EGC (2024 KAMA scientific convention)

2024-21. ¾Ë½ö´Þ½ö ÄûÁî (7ȸ)

Dr Ville ¼¼¹Ì³ª. Log-in é©

2024-21. ÇϺνĵµ¼±¾Ï°ú ¸²ÇÁÀý¸í¸í¹ý. Lower esophageal adenocarcinoma

ECR 016

2024-20. Post-colonoscopy surveillance. ÀÓ»ó°­»ç ¿À¿µÀº

2024-10-7.

2024-19. ESD complication (pneumonia) and atypia

ECR 015

2024-18. ½ÊÀÌÁöÀå±Ë¾çÃâÇ÷ Áõ·ÊÅäÀÇ. Duodenal ulcer bleeding

ECR 014

2024-17. Presidential Lecture at KINGCA WEEK 2024. Endoscopy and gastric cancer

In English

2024-16. Endoscopy open education with EndoTODAY and ESD hands-on training

In English

2024-15. Gastric MALToma treated by RT

Àú´Â ¾Æ³¦¾øÀÌ ÁÖ´Â ¼±»ýÀÔ´Ï´Ù. »ç¶ûÇÏ´Â ÇÐȸ·ÎºÎÅÍ ¾Æ³¦¾øÀÌ ÁÖÁö´Â ¸»¶ó´Â °æ°í¸¦ ¹ÞÀºÁö 3ÁÖ°ÀÔ´Ï´Ù. ±×·¸´Ù°í ¾Æ²¸°¡¸ç ÁÙ ¼ö´Â ¾ø´Â ÀÏ ¾Æ´Ï°Ú½À´Ï±î. ¼±»ýÀ̶ó´Â Á÷¾÷ÀÇ åöÀÇ Æ¯¼ºÀÌ ¿ø·¡ '¹è¿ö¼­ ³²ÁÖ´Â °Í'ÀÏÁøµ¥ ¾îÂî ¾Æ³¢¶ó´Â ¸»ÀԴϱî. ±×·¡¼­ ±×³É ¿ø·¡ ÇÏ´ø´ë·Î Çϱâ·Î Çß½À´Ï´Ù. °è¼Ó ¾Æ³¦¾øÀÌ ÁÖ°Ú½À´Ï´Ù.

ÀÌÁ¦ ¸¶À½ ¼ÓÀÇ ÅÂdzµµ Á¶±Ý¾¿ °¡¶ó¾É°í ÀÖ½À´Ï´Ù. ÀÌ·± °æ¿ì °øÀÚ´Â µµ¿òÀÌ µÇÁö ¾Ê¾Ò½À´Ï´Ù. ¿ª½Ã ³ëÀÚÀÔ´Ï´Ù.

À§ MALT ¸²ÇÁÁ¾¿¡ ´ëÇÑ »ó¼¼ÇÑ Áõ·ÊÅäÀÇÀÔ´Ï´Ù. µµ¿òÀÌ µÇ±â ¹Ù¶ø´Ï´Ù.

ECR 013

2024-14. 2024³â ´ëÇѼÒÈ­±â³»½Ã°æÇÐȸ ¡°è »çŵµ 2ÁÖ°¡ µÇ¾ú½À´Ï´Ù. Á¤½ÅÀ» Â÷¸®°í ´Ù½Ã ¿ø·¡ÀÇ ¸ð½ÀÀ¸·Î µ¹¾Æ°¡·Á°í ÇÕ´Ï´Ù. ±×·¡¼­ ±³À° ÀڷḦ Çϳª ¸¸µé¾ú½À´Ï´Ù.

ECR 012

2024-13. ¾¦½º·´Áö¸¸... ȯÀÚ¾ÈÀüÁ¦µµ °øÇå À¯°øÀÚ Ç¥Ã¢À» ¹Þ¾Ò½À´Ï´Ù.

[µ¿¹®¼Ò½Ä] Ⱦ¹®±ÙÀ¶ÇØÁõ

2024-12. Case Reviews in Gastroenterology Ⱓȣ

PDF 37.7M

2024-11. ¾Ë½ö´Þ½ö Q & A ÄûÁî (6ȸ)

Dr. Ville ¼¼¹Ì³ª. log-in é©

2024-10. BOXIM simulator ÈÆ·Ã 2024³â ½Å±Ô ³ìÈ­

BOXIM hands-on training (2024-6)

2024-9. The 6th SMC-MNCC joint symposium 1. Rare complications of ESD (TS Kim), 2. Pitfalls in pathologic evaluation of ESD specimen (SM Ahn), 3. Follow up strategy after endoscopic treatment for early gastric cancer (BH Min), 4. Interesting Mongolian cases (Amarbat, Mongolian National Cancer Center), 5. Interesting Korean cases (JH Lee)

2024-8. À§½Äµµ¿ª·ùÁúȯ°ú ½Äµµ¿­°øÅ»Àå

2024-6

2024-7. ÇÏÀÌ´Ú ÀÎÅͺä. À§¾Ï°ú À§³»½Ã°æ

񃯇

2024-6. ¾Ë½ö´Þ½ö Q & A ÄûÁî (5ȸ)

Dr. Ville ¼¼¹Ì³ª. log-in é©

2024-5. ¿ª·ù¼º ½Äµµ¿°

2024-4. ¼ÒÈ­±â¿Í È£Èí±âÀÇ ¸¸³² (´ÚÅͺô)

log-in ÇÊ¿ä. ÇöÀå ½ºÄÉÄ¡

2024-3. ÀÚ°¡¸é¿ªÀ§¿° (±èż¼)

- Åä·Ð

2024-2. 1Â÷ Áø·á ½Ã Àý´ë ³õÄ¡¸é ¾È µÇ´Â À§³»½Ã°æ ¼Ò°ß ¹× Áõ·Ê

2024-1 ºñ¿ÂµÚ °­¿¬. Àú¿ë·® ¾Æ½ºÇǸ°°ú ºñ½ºÅ×·ÎÀ̵å¼Ò¿°Á¦¸¦ º¹¿ëÇϴ ȯÀÚÀÇ À§±Ë¾ç Ä¡·á


[2023]

2023-17. ÇϹݱ⠺ñ¿ÂµÚ °­¿¬

  1. 9¿ù 8ÀÏ (±Ý) : À§¾ÏÀÇ 5´ë ½ÅÈ£
  2. 10¿ù 13ÀÏ (±Ý): °í·É ȯÀÚÀÇ ³»½Ã°æ ½Ã¼ú
  3. 11¿ù 10ÀÏ (±Ý) : À§³»½Ã°æ¿¡¼­ ÀÚÁÖ ¹ß°ßµÇ´Â À§Á¡¸·ÇÏÁ¾¾ç
  4. 12¿ù 8ÀÏ (±Ý): À§±Ë¾ç°ú ½ÊÀÌÁöÀå±Ë¾ç

2023-16. À§¿° talk. '³»°úÀÇ»ç ¹Ú°úÀå'¿¡ Ã⿬ÇÏ¿´½À´Ï´Ù.

2023-15. DDDW. Fexuclue case review. ±è¿ë¼º, Á¶À¯°æ, ÀÌÁØÇà

2023-11-21. VOD. ´ÚÅͺô log-in é©

2023-14. KDDW. EndoTODAY and endoscopy training

2023-11-16. KDDW °­ÀÇ

2023-13. ¼ÒÈ­±â Àü¹®ÀÇ¿Í ¼øÈ¯±â Àü¹®Àǰ¡ ¹Ù¶óº¸´Â GERD¿Í °¡½¿¾²¸² ¼­¿ïÀÇ´ë ³ª»óÈÆ ±³¼ö´Ô°ú ÇÔ²² - memo

VOD. ´ÚÅͺô log-in é©

2023-12. ³»½Ã°æ Áõ·Ê¸¦ ÅëÇØ È®ÀÎÇÏ´Â ¾Ë½ö´Þ½ö Q&A (2023-7-13) - Feedback, ÇöÀå ½ºÄÉÄ¡

VOD. ´ÚÅͺô log-in é©
PC version

2023-11. Borrmann type 4 gastric cancer (2023)

(subnote)

2023-10. Endoscopic findings of gastric cancers (KINGCA2023)

2023-9. ºñ¿ÂµÚ. Á¤ÁøÈñ¼î. À§¿°°ú ½Äµµ¿°

2023-8. ³»½Ã°æ Áõ·Ê¸¦ ÅëÇØ È®ÀÎÇÏ´Â ¾Ë½ö´Þ½ö Q&A (ÀÌÁØÇà, ±èÁø¿ë, ¼Û°æÈ£, 2023-7-13). ÇöÀ彺ÄÉÄ¡/¸Þ¸ð

VOD. ´ÚÅͺô log-in é©

2023-7. À§¾Ï ³»½Ã°æ Ä¡·á update¿Í ±³ÈÆÀûÀÎ À§¾Ï Áõ·Êµé.

VOD. µ¿¾ÆÁ¦¾à Mediflix log-in é©

2023-6. KSGE webinar. »óºÎÀ§Àå°ü °¨¿°¼ºÁúȯ. ±èÁöÀº, ÀÌÁØÇà. ±¤°í 1/±¤°í 2/ÇöÀå»çÁø/¸Þ¸ð

VOD. KSGE log-in é©

2023-5. Gastric ESD and incomplete resection (a lecture at Ulaanbaatar)

2023-4. ³»½Ã°æ Áõ·Ê¸¦ ÅëÇØ È®ÀÎÇÏ´Â ¾Ë½ö´Þ½ö Q&A (ÀÌÁØÇà, ¼Û°æÈ£)

VOD. ´ÚÅͺô log-in é©

2023-3. ºñ¿ÂµÚ (2023³â 3¿ù ¸ÅÁÖ È­¿äÀÏ Àú³á 10½Ã)

À§¾Ï °ËÁø ³»½Ã°æ Facebook posting

Ç︮ÄÚ¹ÚÅÍ

Á¶±âÀ§¾Ï ³»½Ã°æÄ¡·á

¿ª·ù¼º ½Äµµ¿°

2023-2. FAQ on gastritis À§¿° Áú¹®°ú ´äº¯

2023-1. FAQ on fundic gland polyp À§Àú¼± ¿ëÁ¾ Áú¹®°ú ´äº¯

* Âü°í: EndoTODAY À§Àú¼± ¿ëÁ¾°ú À§Àú¼± ¿ëÁ¾Áõ Fundic gland polyp and fundic gland polyposis


[2022]

2022-72. ¿ëÁ¾ÀýÁ¦¼ú µµ±¸. ¼º°á ±³¼ö´Ô

2022-71. ºñ¿ÂµÚ Á¤ÁøÈñ¼î Ã⿬

2022-12-6

2022-70 ³»½Ã°æ µ¹¾Æº¸±â, ½ÊÀÌÁöÀå ¸²ÇÁÁ¾ (ÀÌÁØÇà)

* Âü°í: EndoTODAY ½ÊÀÌÁöÀå ¼ÒÆ÷ ¸²ÇÁÁ¾ Duodenal follicular lymphoma

2022-69. ³»½Ã°æ ÀÇ»çÀÇ ±Ù°ñ°Ý°è ÀÌ»ó. KDDW 2022 (ÀÌÁØÇà)

2022-68. À§¿°, gastritis (½Å¿î°Ç ±³¼ö´Ô)

´ÚÅͺô log-in é©

2022-67. 2023³â ½ÅÀÓ GI Fellow¸¦ À§ÇÑ DEX

2022-66. À§½ÄµµÁ¢ÇպξÏÀÇ Siewert ºÐ·ù

2022-65. ±Þ¸¸¼º È£Èí±âÁúȯÀÚÀÇ ³»½Ã°æ. ³ë¿øÀ»Áöº´¿ø À̺´ÈÆ

2022-64. À§¿°. ÀÌÁØÇà

2022-63. Áß°£¾Ï. ±èÅÂÁØ

- Áú¹®°ú ´äº¯

2022-62. ÀÚ°¡¸é¿ªÀ§¿°. ¾È¿ëȯ

- Áú¹®°ú ´äº¯

2022-61. Bleeding after ESD. Nextbiomedical symposium

2022-60. Endoscopy ergonomicx. SGI

2022-59. Á¦1ȸ ESD Áý´ãȸ 2022³â 10¿ù 11ÀÏ

2022-58. ESD training in Korea - 20221111 Pentax Forward Academy

2022-57. ´ÚÅͺô Helicobacter symposium - (1) Hp Á¦±ÕÄ¡·á¿Í FD Áõ»ó°³¼± È¿°ú (¹ÚÁ¤È£) (2) Hp Á¦±ÕÄ¡·á¿Í À§¾Ï¹ß»ý°úÀÇ ¿¬°ü¼º (Á¤À±¼÷) (3) ÁÂÀå Áõ·Ê ÅäÀÇ (ÀÌÁØÇà)

·Î±×ÀÎ ÇÊ¿ä

2022-56. IBD dysplasia (¾çµ¿ÈÆ ±³¼ö´Ô) - ¿°Áõ¼º ÀåÁúȯ, DALM, Surveillance

2022-55. Sessile serrated lesions ¹«°æ¼º Åé´Ïº´º¯ÀÇ ³»½Ã°æ Áø´Ü ¼ú±â (±èÇö°Ç ±³¼ö´Ô)

ÇöÀå ½ºÄÉÄ¡ Webserminar Áú¹®

2022-54. Á÷½Ã°æ °Ë»ç¿¡¼­ ³õÄ¡±â ½¬¿î ½ÊÀÌÁöÀå ¹× À¯µÎºÎ Áúȯ (Á¶ÀçÈñ ±³¼ö´Ô)

2022-53. Endoscopic treatment of gastric cancer (ÀÌÁØÇà, KINGCA2022)

2022-52. À§Àå°üÃâÇ÷ÀÇ ÀÀ±Þ³»½Ã°æ (±èÁöÀº ±³¼ö´Ô)

2022-51. ±â´É¼º ¼ÒÈ­ºÒ·®Áõ (È«ÁöÅà ±³¼ö´Ô)

2022-50. Submucosal invasion in forceps biopsy

2022-49. GI intervention, lymphatic approach (Çöµ¿È£ ±³¼ö´Ô)

2022-48. Patient-specific GI route. Stent and PEG (±èÅÂÁØ ±³¼ö´Ô)

2022-47. CT ³»½Ã°æ. CT gastroscopy (Á¤¿ì°æ ±³¼ö´Ô)

2022-46 Helicobacter 2022

2022-45 ESD knife (°ø¼º¹Î ±³¼ö´Ô)

2022-44 Fexuprazan

´ÚÅͺô (log-in é©)

2022-43. Atypia. Atypical glands. Atypical cells. ºñÀüÇüÀû ¼Ò°ß. ÀÎõ½Ã³»°úÀÇ»çȸ

2022-42. Koken simulator¸¦ ÀÌ¿ëÇÑ ³»½Ã°æ »ðÀÔ°ú °üÂû. Á¦66ȸ ³»½Ã°æ¼¼¹Ì³ª (2022-8-21)

2022-41. À§Àå°ü ±â»ýÃæ (2022) SMC ¼ÒÈ­±âº´ ½ÉÆ÷Áö¾ö

- Àüüº¸±â

2022-40. °íÁ֯Ĺ߻ýÀåÄ¡. Electrosurgical Unit. ESU (±è¹ÎÁö ±³¼ö´Ô)

2022-39. Endoscopic snares (¼º°á ±³¼ö´Ô)

2022-38. ¹ÌºÐÈ­ Á¶Á÷Çü Á¡¸·¾ÏÀÇ ¸²ÇÁÀý ÀüÀÌ Áõ·Ê (2022-6-19. Live pig ESD hands-on training. ¿Ã¸²Çª½º ¼Ûµµ K-TEC training center)

2022-37. Preparation of figures (2022-6-11. IDEN 2022)

2022-36. Áõ·Ê·Î »ìÆìº¸´Â ¼ÒÈ­¼º±Ë¾ç. ÀÌÁØÇà. ºÎ»ê¿¡¼­

2022-35. Seoul Consensus on GERD (¹ÚÂùÇõ ±³¼ö´Ô)

2022-34. ³»½Ã°æ ÁöÇ÷µµ±¸ (À̵¿±Ô ±³¼ö´Ô)

2022-33. Helicobacter treatment for MALT lymphoma. MALToma Ä¡·á (ÀÌÇõ ±³¼ö´Ô)

Á¦15ȸ SMC ³»½Ã°æ¼¼¹Ì³ª - Single topic symposium on gastric MALToma

2022-32. Endoscopic diagnosis of MALT lymphoma. MALToma ³»½Ã°æ Áø´Ü (¼º°á ±³¼ö´Ô)

Á¦15ȸ SMC ³»½Ã°æ¼¼¹Ì³ª - Single topic symposium on gastric MALToma

2022-31. ESD ¼Ò°³. ESD knife¿Í ESU¸¦ Áß½ÉÀ¸·Î.

2022-30. Drug-induced gastropathy. ¼ÒÈ­¼º±Ë¾ç Áõ·Ê ÅäÀÇ

´ÚÅͺô. log-in é© (2700¸íÀÌ ³Ñ´Â ºÐ²²¼­ ´ÊÀº½Ã°£±îÁö °­ÀÇ Âü¼®ÇØÁּ̰í, 2365¸íÀÇ ¼±»ý´Ôµé²²¼­ ¼³¹® ÁøÇàÇØÁּ̽À´Ï´Ù. ±Ù¹« º´¿ø ÇüÅ´ °³¿øÀÇ 544¸í, ¼¼¹Ìº´¿øÀÌ»ó 1263¸í, º¸°Ç¼Ò ¹× ¿ä¾çº´¿ø 343¸í ¿Ü À̸ç, ¸¸Á·µµ Á¶»ç¿¡¼­ 96%ÀÌ»óÀÇ Âü¿©ÀںеéÀÌ ¸¸Á·ÀÌ»óÀÇ ´äº¯À» ÀÛ¼ºÇØÁּ̽À´Ï´Ù.) - feedback

2022-29. ¹Ù·¿ ½Äµµ. ¿ª·ù¼º ½Äµµ¿°. Ç츣Æä½º ½Äµµ¿°

2022-28. È£Èí±âÁúȯ°ú GERD (À̺´ÈÆ ±³¼ö´Ô)

- À̳뿣 EndoTODAY webseminar Àüü º¸±â

2022-27 Esophageal varix (¿ÀÁÖÇö ±³¼ö´Ô)

2022-26 KSGE Web-seminar. ¼ÒÈ­¼º±Ë¾ç Áõ·ÊÅäÀÇ. ±èÁ¤È¯, ±èÅÂÁØ, ÀÌÁØÇà

KSGE VOD (log-in é©)

2022-25. Single topic symposium on esophageal varix grading °í¸íÁö, ¹Ú¿¹¿Ï

F1 (linear, < 5mm)°ú F2 (beaded or tortuous, >5mm)ÀÇ ±¸ºÐÀÌ ¾Ö¸ÅÇϸé F1À¸·Î ÁØ´Ù. ¾à°£ beaded ÇÑ ¸ð¾çÀÌ´õ¶óµµ 5mm ¹Ì¸¸À̸é F1À¸·Î ÁØ´Ù.

F2¿Í F3ÀÇ ±¸ºÐÀº ÀÓ»óÀûÀ¸·Î º° Â÷À̰¡ ¾ø´Ù.

¾Ö¸ÅÇÏ¸é ¼¼°Ô Áֱ⺸´Ù´Â ¾àÇÏ°Ô ÁØ´Ù.

EVLÀ» ¿©·¯¹ø ½ÃÇà¹ÞÀº ȯÀÚ¿¡¼­´Â F1,2,3 ±¸ºÐÀÌ ¾î·Æ´Ù. Ä¡·á°¡ ÇÊ¿äÇÏ´Ù°í ÆÇ´ÜµÇ¸é F2, Ä¡·á°¡ ÇÊ¿äÇÏÁö ¾Ê´Ù°í ÆÇ´ÜµÇ¸é F1À» Áֱ⵵ ÇÑ´Ù. »çÁøÀ» Àß Âï¾îµÎ´Â °ÍÀÌ Áß¿äÇÏ´Ù.

* Âü°í: EndoTODAY ½ÄµµÁ¤¸Æ·ù

2022-24. Salvage surgery after ESD for EGC in the elderly

2022-4-9. ¼Ûµµ Olympus K-TEC

2022-23. Case review. EGC with venous invasion

2022-4-9. ¼Ûµµ Olympus K-TEC

2022-22. ¼ÒÈ­±â Áúȯ¿¡¼­ ¿Ã¹Ù¸¥ Ç×»ýÁ¦ »ç¿ë (°­Ã¶ÀÎ ±³¼ö´Ô)

2022-21. À§¿°. ´ëÀå³»½Ã°æ»ðÀÔ¹ý

Keymedi (log-in é©)

2022-20. Extrapulmonary paragonimiasis

2022-19. Endoscope. Low dose PPI for gastritis. Neuroendocrine tumor.

2022-18. À§»óÇÇÇÏÁ¾¾ç. GIST¿Í °¨º°Áø´Ü

2022-17. (1) ±Ë¾çÀΰ¡ ¹Ì¶õÀΰ¡? (2) ±Ë¾çÀΰ¡ ¾ÏÀΰ¡? (3) Refractory GERD&FDÀÇ Ä¡·á¿É¼Ç. ¼­¿ï´ë À̵¿È£ ±³¼ö´Ô°ú ÇÔ²². ´ÚÅͺô web-seminar

´ÚÅͺô. log-in é©

2022-16. In depth case analysis - EGC IIc Ä¡·á¹æÄ§ °áÁ¤. À§Áúȯ³»½Ã°æ¾ÆÆ²¶ó½º Åä·Ð ¸ðÀÓ. 2022-3-7

2022-15. 2022³â 3¿ù 20 (ÀÏ) ³»½Ã°æÇÐȸ¼¼¹Ì³ª °­ÀÇ . ¾ÈÀüÇÏ°í Æí¾ÈÇÑ ³»½Ã°æ »ðÀÔ¹ý°ú º´º¯À» ³õÄ¡Áö ¾Ê±â À§ÇÑ °üÂû¹ý

2022-14. À§¿°. Çлý °­ÀÇ

2022-13. 2022-2-19. Winter School. ¿°Áõ¼º ÀåÁúȯ (±è¿µÈ£ ±³¼ö´Ô)

2022-13. 2022-2-19. Winter School.ÇϺÎÀ§Àå°üÃâÇ÷ (È«¼º³ë ±³¼ö´Ô)

2022-12. 2022-2-19. Winter School. À§¾ÏÀ» ³õÄ¡Áö ¾Ê´Â ³»½Ã°æ °üÂû¹ý (±èÅÂÁØ ±³¼ö´Ô)

2022-11. 2022-2-19. Winter School. Quick Reference (ÀÌÁØÇà)

2022-10 À̳뿣 ³»½Ã°æ ¾ÆÆ²¶ó½º Åä·Ð¸ðÀÓ. Angiodysplasia. Neuroendocrine carcinoma

2022-9 5¿ù 22ÀÏ À§´ëÀå³»½Ã°æÇÐȸ on-line Çмú´ëȸ. »óºÎÀ§Àå°ü Áõ·Ê

2022-8 [Case] ESD for signet ring cell carcinoma (M/46)

2022-7 À§¾ÏÀÇ ¿¹¹æ (¼­½ÂÀÎ ±³¼ö´Ô)

2022-6 Laryngopharyngeal reflux disease (LPRD) ¼­¿ï´ë À̺ñÀÎÈİú Á¤¿ìÁø

2022-5 (1) GERDÀÇ ÃֽŠÁö°ß, (2) Helicobacter Á¦±ÕÄ¡·á ÈÄ ¹ß°ßµÈ À§¾Ï (3) NK cell (Á¶´ö)

Á¶´ö ±³¼ö´ÔÀÇ °­ÀǸ¦ º¹½ÀÇÏ¿´½À´Ï´Ù.

2022-4 (1) GERDÀÇ ÃֽŠÁö°ß, (2) Would you do ESD? (3) ¼öÇ÷

2022-3 (1) ±×°ÍÀÌ ¾Ë°í½Í´Ù, ¼ÒÈ­±â ³»°ú Áø·áÇöÀå¿¡¼­ ³ª¿Â ¾à¸®Çп¡ °üÇÑ Áú¹®µé, (2) GERDÀÇ ³»½Ã°æ Áø´Ü

2022-2 (1) ´Ù¾çÇÑ °£ Á¾±«ÀÇ ÃÊÀ½ÆÄ ¼Ò°ß, (2) À§¿°ÀÇ Áø´Ü°ú Ä¡·áÀÇ °ú°Å, ÇöÀç ±×¸®°í ¹Ì·¡

´ë¿øÁ¦¾à D Talks

2022-1 ÆÇµ¶ÀÌ ¾î·Á¿î Áõ·Ê


[2021]

2021-53. GERD Àç¹ß ¹æÁö ³ëÇÏ¿ì. »ó±Þº´¿øÀ¸·Î transfer µÇ´Â ÄÉÀ̽º (±Ýº¸¶ó ±³¼ö´Ô)

´ÚÅͺô (·Î±×ÀÎ é©)

2021-52. À§¾Ï ȤÀº ¸²ÇÁÁ¾, º¸¸¸ 2Çü À¯»ç DLBCL, CMV colitis, Candida esophagitis (ÀÓ»ó°­»ç °ß¿ìÁø)

2021-51. À§¾ÏÀÇ Àӯļ± ÀüÀ̰¡ ÀǽɵǾú´ø °áÇÙ¼º Àӯļ±¿° (Àü¼º¿ì ±³¼ö´Ô)

2021-50. »ý¼± °¡½Ã·Î ÀÎÇÑ ½Äµµ À̹° õ°øÀÇ ³»½Ã°æ Ä¡·á (Àü¼º¿ì ±³¼ö´Ô)

2021-49. GI stent hands-on training

2021-10-8. »ï¼ºµ¿ M.I.Tech ³»½Ã°æ ÈÆ·Ã½Ç

2021-48. À§¾Ï ¼ö¼ú ÈÄ ºñŸ¹Î Åõ¿© sentinel polyp (EndoTODAY ¼ö¿ä³»½Ã°æ¼¼¹Ì³ª)

2021-47. ½Äµµ °áÇÙ, ½Å°æÃÊÁ¾, º£Ã¼Æ® Àå¿°. ¸ñ¿ä³»½Ã°æÁý´ãȸ ÄûÁî ÇØ¼³ (¹Ú¿¬Á¤)

2021-46. À§¿°°ú Ç︮ÄÚ¹ÚÅÍ. Á¦13ȸ SMC ³»½Ã°æ¼¼¹Ì³ª (ÀÌÁØÇà)

2021-45. Á¦13ȸ SMC ³»½Ã°æ¼¼¹Ì³ª ±èÀº¶õ ±³¼ö´Ô, °ø¼º¹Î ±³¼ö´Ô

2021-44. Cold snare polypectomy for larger polyps. Àӹαâ

2021-9-8. SMC ¸ñ¿äÁ¡½É³»½Ã°æ¼¼¹Ì³ª

2021-43. Á¶±âÀ§¾Ï ³»½Ã°æ Ä¡·á. ÀûÀÀÁõ°ú ±¹¼Ò Àç¹ß

2021-9-8. SK EndoTODAY ³»½Ã°æ ¼¼¹Ì³ª

2021-42. ¸¸¼º °£Áúȯ ȯÀÚ¿¡¼­ÀÇ ³»½Ã°æ (³ë¿øÀ»Áöº´¿ø ¿ÀÁÖÇö)

2021-9-8. SK EndoTODAY ³»½Ã°æ ¼¼¹Ì³ª

2021-41. À§±Ë¾çÀÇ Áø´Ü

2021-9-6. ¿¡ÀÚÀÌ ¼øÃµ¸¸ ³»½Ã°æ ¼¼¹Ì³ª

2021-40. Ç︮ÄÚ¹ÚÅÍ À½¼º À§¾Ï. À§¿ëÁ¾. À§¼±Á¾ - À̳뿣 talk show

(Àüü º¸±â)

2021-39. COVID 19 pandemic ½Ã´ëÀÇ ³»½Ã°æ. ³²ÁöÇö

2021-38. À§¾Ï Ä¡·á ÈÄ Àç¹ß¾ÏÀÇ ´Ù¾çÇÑ ¼Ò°ß (2021-9-12. ´ëÇÑÀ§´ëÀå³»½Ã°æÇÐȸ Ãß°èÇмú´ëȸ on-line)

2021-37. ¸ñ¿ä³»½Ã°æÁý´ãȸ ÄûÁî ÇØ¼³. ÀÜÀ§¾Ï, lymphoepithelioma-like carcioma, ´ëÀå ÀüÀÌ, melanoma, CMV colitis (ÇǽÂÈÆ)

2021-36. ¸ñ¿ä³»½Ã°æÁý´ãȸ Áõ·ÊÅäÀÇ. GIST, È£»ê±¸ ½Äµµ¿°, ½ÄµµÇùÂø (ÇǽÂÈÆ)

2021-35. ¸ñ¿ä³»½Ã°æÁý´ãȸ Áõ·ÊÅäÀÇ. º¸¸¸ 4Çü ÁøÇ༺À§¾Ï. ±èÇü·¡

2021-34. ¸ñ¿ä³»½Ã°æÁý´ãȸ Áõ·ÊÄûÁî. ±èÇü·¡

2021-33. Helicobacter - Æ÷Áö¼ÇÀ» Á¤ÇÏÀÚ. ÀÌÁØÇà. 2021-8-5 SK ÇÁ·Î¸Æ ³»½Ã°æ¼¼¹Ì³ª 2021-8-4

2021-32. EndoTODAY Áõ·Ê ÅäÀÇ - ¼ÒÈ­¼º ±Ë¾ç. ÀÌÁØÇà. 2021-8-5 SK ÇÁ·Î¸Æ ³»½Ã°æ¼¼¹Ì³ª 2021-8-4

2021-31. À§±Ë¾ç°ú À§¾ÏÀÇ °¨º°Áø´Ü. »ï¼ºÃ¢¿øº´¿ø °ø¼º¹Î ±³¼ö´Ô. 2021-8-5 SK ÇÁ·Î¸Æ ³»½Ã°æ¼¼¹Ì³ª 2021-8-4

2021-30. ¼ÒÈ­¼º ±Ë¾ç ÃâÇ÷°ú ±âŸ ÇÕº´Áõ. »ï¼ºÃ¢¿øº´¿ø °ø¼º¹Î ±³¼ö´Ô. 2021-8-5 SK ÇÁ·Î¸Æ ³»½Ã°æ¼¼¹Ì³ª 2021-8-4

2021-29. ³»½Ã°æ Áõ·Ê ÅäÀÇ (¹ÚÁö¿¬). RT-induced gastropathy

2021-28. ³»½Ã°æ Áõ·Ê ÄûÁî (¹ÚÁö¿¬). EG junction cancer, Gastric lymphoma, Tuberculous peritonitis

2021-27. TED symposium. Gastric ESD Training and Practice with Pentax Imagina Endoscope and Finemedix ClearCut Knife

2021-26. ³»½Ã°æ Áõ·Ê ÅäÀÇ (À̼öÇö). Hyperplastic polyp with focal adenomatous change. Esophageal foreign body with perforation

2021-25. ³»½Ã°æ Áõ·Ê ÄûÁî (À̼öÇö). Upper esophageal adenocarcinoma. Gastric SMT. Amebic colitis. Colon tubulovillous adenoma

2021-24. SK ³»½Ã°æ ¼¼¹Ì³ª ½Ã¸®Áî. °íÀ§Çè ȯÀÚ¿¡¼­ÀÇ ¾ÈÀüÇÑ ³»½Ã°æ (ÇѸ²´ëÇб³ ¼º°á)

¾Æ·¡°ú °°Àº ´ñ±ÛÀÌ ÀÖ¾ú½À´Ï´Ù.

2021-23. SK ³»½Ã°æ ¼¼¹Ì³ª ½Ã¸®Áî - ´ëÀå¿ëÁ¾ÀýÁ¦¼ú°ú ÃßÀû°üÂû³»½Ã°æ (±èÅÂÁØ)

2021-22. SMC webseminar - Á¶±âÀ§¾Ï ESD update 2021

2021-21. Helicobacter pylori 2021

2021-20. GERDÀÇ È£Èí±â ¹× ÀÎÈĺΠÁõ»ó

2021-19. ¼ÒÈ­¼º ±Ë¾ç ÃâÇ÷

2021-6-3 ¸ñ¿äÁý´ãȸ

2021-18. ¿ª·ù¼º ½Äµµ¿° ³»½Ã°æ ¼Ò°ß - mucosal break¸¦ Áß½ÉÀ¸·Î

2021-17. À§¾Ï °£ÀüÀÌ¿¡ ´ëÇÑ metastatectomy ÈÄ ÀÜÀ§¿¡¼­ ¹ß»ýÇÑ Á¶±âÀ§¾Ï¿¡ ´ëÇÑ ESD Áõ·Ê. ´ëÇÑ»óºÎÀ§Àå°üÇ︮ÄÚ¹ÚÅÍÇÐȸ Áý´ãȸ. ³ªÁöÀº ¼±»ý´Ô ¹ßÇ¥

2021-16. ³»½Ã°æÀ¸·Î º¸´Â ¾Ï Áø´Ü Æ÷ÀÎÆ®

2021-15. Á¦1ȸ SEENET ³»½Ã°æ Áý´äȸ. ÀÌÁØÇà Æ¯°­. ½Äµµ À̹°. Esophageal foreign body

2021-14. Á¦1ȸ SEENET ³»½Ã°æ Áý´äȸ. ¼º°á ¹ßÇ¥. ½Äµµ À̹°. Esophageal foreign body

2021-13. Á¦1ȸ SEENET ³»½Ã°æ Áý´äȸ. À̵¿±Ô ¹ßÇ¥. Herniated gastric mucosa with cancerous transformation

2021-12. Á¦1ȸ SEENET ³»½Ã°æ Áý´äȸ. Gastitis cystica. Metachronous recurrence after ESD (À̼öÇö ¹ßÇ¥)

2021-11. Ç×¾ÏÄ¡·á/¸é¿ª¾ïÁ¦Ä¡·á ȯÀÚÀÇ BÇü °£¿° reactivation ¿¹¹æ

Á¦37ȸ ´ëÇÑÀ§´ëÀå³»½Ã°æÇÐȸ Ãá°èÇмú´ëȸ

2021-10. Remnant gastric cancer. ÀÜÀ§¾Ï

¼øÃµ¸¸³»½Ã°æ¼¼¹Ì³ª

2021-9. One point lesson 2021-4-12

2021-8. °ËÁø °á°ú ¾Ë·Áµå¸®±â, °ú°Å ÀÚ·á¿¡ ±Ù°ÅÇÑ Ç︮ÄÚ¹ÚÅÍ Ä¡·á, À§¿ëÁ¾ÀýÁ¦¼ú, ¿Ü·¡¿¡¼­ ¸¸³ª´Â ¿©·¯ »óȲ (2021-4-1. ¸ñ¿ä³»½Ã°æÁý´äȸ ÀÌÁØÇà °­ÀÇ)

2021-7. Achalasia, Anemia, Spontaneous bleeding, Duodenal varix, Rectal MALToma (2021-2-18 Á¤ÅÂ¾ç ¼±»ý´Ô ¹ßÇ¥)

2021-6. Herpetic esophagitis, Remnant gastric cancer (AGC), Rectal melanoma (2021-2-18 Á¤ÅÂ¾ç ¼±»ý´Ô ¹ßÇ¥)

2021-5. 1 adenoma, 1 EGC, 1 AGC - ¼±Á¾ Çϳª (ÀýÁ¦¼ú ±ÇÇßÀ¸³ª ¼ÒÀÛ¼ú ¿øÇÏ¼Ì°í ½Ã¼ú Çϸ鼭 ÀýÁ¦¼ú + ¼ÒÀÛ¼ú ½ÃÇà), EGC Çϳª (IIa + IIc. SM2 invasionÀ̾ú°í ¸²ÇÁÀý ÀüÀ̰¡ ¸¹¾ÒÀ½), AGC Çϳª (8°³¿ù Àü ³»½Ã°æ °Ë»ç¸¦ ¹ÞÀ¸¼Ì´ø º¸¸¸ 4Çü ÁøÇàÀ§¾Ï)

2021-4. SMT like cancer, GAVE, Ileal lymphoma Á¡¸·ÇÏÁ¾¾ç°ú ºñ½ÁÇÑ À§¾Ï, ¼ÒÀå ¸²ÇÁÁ¾

2021-3. ½Äµµ °ú¸³¼¼Æ÷Á¾, ¹æ»ç¼± Á÷Àå¿°, Àڱ󻸷Áõ. Granular cell tumor, RT induced proctitis, Endometriosis

2021-2. Ectopic sebaceous gland, Borrmann type IV, Pancreas cancer with duodenal invasion, Cowden syndrome (±è¼ÒÀ±)

2021-1. 1¿ù 9ÀÏ ºÎ»ê Ç︮ÄÚ¹ÚÅÍ½ÉÆ÷Áö¾ö ÀÌÁØÇà °­ÀÇ


[2020]

ÁßȯÀÚ½Ç ³»½Ã°æ°ú ½ºÆ®·¹½º ±Ë¾ç ¿¹¾à

2020-7-7. YouTube ½Ç½Ã°£ °­ÀÇ

2020-24. º¸¸¸ 4Çü ÁøÇ༺À§¾Ï. AGC Borrmann type 4

2020-23. Achalasia, lymphoma, EG junction cancer, Trichuris trichiura, EGC arising from hyperplastic polyp

2020-22. Esophageal diverticulum, anal melanoma, Henoch Scholein purpura, colonic invasive aspergillosis, esophageal neuroendocrine carcinoma

2020-21. Hiatal hernia Achalasia EGC Cowden NET (´ëÇÑÀ§´ëÀå³»½Ã°æÇÐȸ on-line °­ÀÇ) - ÇÐȸ 1´Þ ÈÄÀÎ 7¿ù 7ÀϺÎÅÍ YouTube¿¡¼­ ½ÃûÇÏ½Ç ¼ö ÀÖ½À´Ï´Ù.

2020-20. Cowden syndrome Ä«¿ìµ§ ÁõÈıº

2020-19. Inlet patch, lymphangioma, cavernous hemanioma, rectal carcinoid

2020-18. FAP. Familial adenomatous polyposis. °¡Á·¼º ¼±Á¾¼º ¿ëÁ¾Áõ

2020-17. Hereditary non-polyposis colorectal cancer (HNPCC) = Lynch syndrome, À¯Àü¼º ´ëÀå¾Ï

2020-16. ¹Ù·¿ ½Äµµ¾Ï, À§½Å°æ³»ºÐºñÁ¾¾ç, ÇãÇ÷¼º Àå¿°, ´ëÀå ÀüÀÌ

2020-15. ¹Ì¶õÀΰ¡, ±Ë¾çÀΰ¡, Ȥ½Ã ¾ÏÀº ¾Æ´Ñ°¡?

[Special] Ç︮ÄÚ¹ÚÅÍ¿¡ ´ëÇÑ »ç°ß (2020)

2020-14. À§¾Ï, À§¿ëÁ¾Áõ (Cowden syndrome), ³»½Ã°æ »çÁø°ú ³»½Ã°æ ½Ã½ºÅÛÀÇ button ÀÍÈ÷±â

2020-13. ½Äµµ¾Ï, amyloidosis, extrinsic compression

[Special] ¼øÃµ¸¸ ³»½Ã°æ ¼¼¹Ì³ª Ư°­: À§Àå°ü °Ô½ÇÁõ

2020-12. Introduction to IEE (image enhanced endoscopy)

2020-11. One point lesson - ÀÀ±Þ³»½Ã°æ°ú ±Ý½Ä±â°£, actinomycosis, CMV ½Äµµ¿°

2020-10. ½ÄµµÁúȯ ³»½Ã°æ »çÁø Åä·Ð. Mucosal break, hiatal hernia, achalasia, esophageal ESD

2020-9. Quiz ÇØ¼³ (¼º°á) - »óºÎ½Äµµ¾Ï, À§¾Ï°ú À§±Ë¾ç, Ç×¹® Èæ»öÁ¾, Á÷Àå MALToma

2020-8. À§Ã༺ À§¿°, ¿ÍÆÄ¸°, ³­Ä¡¼º ±Ë¾ç, º¯ºñ

2020-7. Quiz ÇØ¼³ (¿ÀÁÖÇö)

2020-6. Quiz ÇØ¼³ (±è¹ÎÁö)

2020-5. ½Äµµ Áúȯ FAQ. ¹«Áõ»ó ½Äµµ Ä­µð´ÙÁõ, Sloughing esophagitis, ½Äµµ black pigmentation, ½Äµµ dysplasia, Achalasia, Diffuse idiopathic skeletal hyperostosis

2020-4. ³»½Ã°æ °Ë»ç Àü ¾Æ½ºÇǸ° Áß´Ü, Ç︮ÄÚ¹ÚÅÍ Á¶Á÷°Ë»ç, MALToma ÃßÀû°Ë»ç µî fellow ¼±»ý´ÔµéÀÇ Áú¹®¿¡ ´äÇÕ´Ï´Ù.

2020-3.

2020-2.

2020-1.


[2019]

³»½Ã°æ Áõ·Ê ÄûÁî 2019-19 - Marginal ulcer, stricture, fibroblastic polyp, Churg-Strauss

³»½Ã°æ Áõ·Ê ÄûÁî 2019-18 - Neuroendocrine carcinoma, Colon T cell lymphoma

³»½Ã°æ Áõ·Ê ÄûÁî 2019-17 - ½Äµµ¾Ï ¼ö¼ú ÈÄ suture granuloma, Chlamydia trichomatis Á÷Àå¿°

³»½Ã°æ Áõ·Ê ÄûÁî 2019-16 - ½Äµµ¾Ï ¼ö¼ú ÈÄ À§¾Ï

³»½Ã°æ Áõ·Ê ÄûÁî 2019-15 - Fundoplication, white nipple sign

³»½Ã°æ Áõ·Ê ÄûÁî 2019-14 - Fundic gland polyp/polyposis

³»½Ã°æ Áõ·Ê ÄûÁî 2019-13

³»½Ã°æ Áõ·Ê ÄûÁî 2019-12

³»½Ã°æ Áõ·Ê ÄûÁî 2019-11

³»½Ã°æ Áõ·Ê ÄûÁî 2019-10

³»½Ã°æ Áõ·Ê ÄûÁî 2019-9

³»½Ã°æ Áõ·Ê ÄûÁî 2019-8

³»½Ã°æ Áõ·Ê ÄûÁî 2019-7

³»½Ã°æ Áõ·Ê ÄûÁî 2019-6

³»½Ã°æ Áõ·Ê ÄûÁî 2019-5

³»½Ã°æ Áõ·Ê ÄûÁî 2019-4

³»½Ã°æ Áõ·Ê ÄûÁî 2019-3

³»½Ã°æ Áõ·Ê ÄûÁî 2019-2

³»½Ã°æ Áõ·Ê ÄûÁî 2019-1


[Quiz¿Í Áõ·Ê]

1) ½ÊÀÌÁöÀå ³»½Ã°æ »çÁø ÇÑ Àå

2) º¹ºÎ »çÁø ÇÑ Àå

3) À§¾Ï°ú ¾ç¼ºÀ§±Ë¾ç °¨º° 6¿¹

4) ÇϺνĵµ ³»½Ã°æ »çÁø 4 Àå - ÇØ¼³

5) ¾î¶² º´À¸·Î ¿À·¡ ´Ù´Ï½Ã´Â ºÐ

6) »çÁø ÇÑ ÀåÀ¸·Î ÃßÁ¤Çϱâ

7) ½ÊÀÌÁöÀå ±¸ºÎ º´¼Ò

8) »çÁø ÇÑ ÀåÀ¸·Î ÃßÁ¤Çϱâ - ³ë¶õ»ö ¾î¶² °Í

9) »çÁø ÇÑ ÀåÀ¸·Î ÃßÁ¤Çϱâ - µé¹® º´¼Ò

10) »çÁø ÇÑ ÀåÀ¸·Î ÃßÁ¤Çϱâ - gastric fundus

11) »çÁø ÇÑ ÀåÀ¸·Î ÃßÁ¤Çϱâ - gastric SMT-like lesion

12) »çÁø ÇÑ ÀåÀ¸·Î ÃßÁ¤Çϱâ - ¾îµÎ¿î »çÁø

13) »çÁø ÇÑ ÀåÀ¸·Î ÃßÁ¤Çϱâ - NBI¿¡¼­ ¾ó·ê´Þ·è

14) ÀüÁ¤ºÎ SMT

15) Globus - normal finding

16) Hiatal hernia

17) Reflux esophagitis of the mid-esophagus

18) Esophageal polypectomy

19) APC ablation for gastric low grade adenoma

20) Fundic gland polyp

21) Duodenal adenomas and fundic gland polyposis in FAP

22) Atrophic gastritis C-III

23) Atrophic gastritis O-I

24) ´ëÀå¼ö¼ú ÈÄ À¯Âø¿¡ ÀÇÇÑ obstructive ileus

25) M/61 À§¾Ï (forceps biopsy: P/D, solid type): »çÁø 1, »çÁø 2, ÀÇ·Ú ÈÄ Àç°Ë »çÁø, º´¸®

26) Áõ·Ê·Î »ìÆìº¸´Â À§¾ÏÀÇ Áø´Ü°ú Ä¡·á 2023/9

27) À§¾Ï Ç×¾ÏÄ¡·á 2023/9


[References]

1) Talkshow Àü¹®°¡µéÀÇ ±íÀÌ ÀÖ´Â ¼ö´Ù 2020-10-21ºÎÅÍ 2022-3-21±îÁö

© ÀÏ¿ø³»½Ã°æ±³½Ç ¹Ù¸¥³»½Ã°æ¿¬±¸¼Ò ÀÌÁØÇà. EndoTODAY Endoscopy Learning Center. Lee Jun Haeng